4.4 Article

Congenital Hypomyelinating Neuropathy Attributable to a De Novo p.Asp61Asn Mutation of the Myelin Protein Zero Gene

Journal

PEDIATRIC NEUROLOGY
Volume 48, Issue 1, Pages 59-62

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pediatrneurol.2012.09.011

Keywords

-

Funding

  1. Research Committee of Spinal Muscular Atrophy at the Ministry of Health, Labor, and Welfare of Japan
  2. National Center of Neurology and Psychiatry [23-6]
  3. Nervous and Mental Disorders and Research Committee for Charcot-Marie-Tooth Disease, Neuropathy, Ataxic Disease, and Research on Applying Health Technology at the Japanese Ministry of Health, Welfare and Labor
  4. Grants-in-Aid for Scientific Research [22590968] Funding Source: KAKEN

Ask authors/readers for more resources

We describe a boy aged 2 years and 11 months with congenital hypomyelinating neuropathy attributable to a de novo heterozygous missense mutation of c.181G>A (p.Asp61Asn) in the myelin protein zero gene. A nerve conduction study indicated markedly reduced motor conduction velocities in the upper and lower extremities. Stimuli of up to 50-100 mA were necessary for nerve activation, suggesting diseased nerves with greatly decreased excitability. A sural nerve biopsy revealed a marked loss of large myelinated fibers, the absence of myelin breakdown products, occasional basal lamina onion-bulb formations, and tomacula-like structures. The p.Asp61Asn mutation is novel in congenital hypomyelinating neuropathy, but was previously reported in a patient with Charcot-Marie-Tooth disease type 1. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available